Detalhe da pesquisa
1.
A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
Am J Hematol
; 92(12): 1287-1294, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28842936
2.
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.
Blood
; 123(19): 3007-15, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24497534
3.
Notch Signaling Promotes Mature T-Cell Lymphomagenesis.
Cancer Res
; 82(20): 3763-3773, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006995
4.
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
Clin Cancer Res
; 26(3): 690-703, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636099
5.
Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients.
Bone Marrow Transplant
; 58(4): 446-451, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36550198
6.
T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy.
Clin Cancer Res
; 23(10): 2506-2515, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27780854
7.
Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas.
Oncotarget
; 8(70): 114474-114480, 2017 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29383095
8.
Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 22(24): 6118-6128, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27334834